Opinion statement
Phyllodes tumor is a rare fibroepithelial neoplasm of the breast with a very variable, but usually benign, course. Formerly known as cystosarcoma phyllodes, the designation “phyllodes tumor” with appropriate qualification regarding malignant potential based on pathologic features is now the agreed-upon term. The most important diagnostic distinction is from fibroadenoma—phyllodes tumors require complete excision with free margins even when pathologic features suggest benignity because of a proclivity to local recurrence. The most important component of therapy is wide surgical excision, and mastectomy is necessary only when free margins cannot be achieved without it. Involvement of axillary nodes is rare, and axillary dissection is not indicated. The role of radiation therapy and chemotherapy is not established and has not been studied in randomized trials due to the rarity of the tumor. At present, there is no consensus that patients with high-grade phyllodes tumors of the breast will benefit from either of these modalities.
Similar content being viewed by others
References and Recommended Reading
Lee B, Pack G: Giant intracanalicular fibroadenomyxoma of the breast. Am J Cancer 1931, 15–2583.
Bernstein L, Deapen D, Ross RK: The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 1993, 71:3020–3024.
Geisler DP, Boyle MJ, Malnar KF, et al.: Phyllodes tumors of the breast: a review of 32 cases. Am Surg 2000, 66:360–366.
Mangi AA, Smith BL, Gadd MA, et al.: Surgical management of phyllodes tumors. Arch Surg 1999, 134:487–492. Important review of results of surgical treatment.
Noguchi S, Yokouchi H, Aihara T, et al.: Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer 1995, 76:1779–1785.
Noguchi S, Aihara T, Koyama H, et al.: Clonal analysis of benign and malignant human breast tumors by means of polymerase chain reaction. Cancer Lett 1995, 90:57–63.
Chaney AW, Pollack A, McNeese MD, Zagars GK:Adjuvant radiotherapy for phyllodes tumor of breast. Radiat Oncol Investig 1998, 6:264–267.
Zissis C, Apostolikas N, Konstantinidou A, et al.: The extent of surgery and prognosis of patients with phyllodes tumor of the breast. Breast Cancer Res Treat 1998, 48:205–210.
Jorge BA, Vargas SB, Rodriguez RR, Martinez CE:Phyllodes tumors of the breast. Eur Radiol 1999, 9:356–360.
Ohta H, Komibuchi T, Nishio T, et al.: Technetium-99msestamibi scintimammography of benign and malignant phyllodes tumors. Ann Nucl Med 1997, 11:37–39.
Corpron CA, Black CT, Singletary SE, Andrassy RJ:Breast cancer in adolescent females. J Pediatr Surg 1995, 30:322–324.
Leveque J, Meunier B, Wattier E, et al.: Malignant cystosarcomas phyllodes of the breast in adolescent females. Eur J Obstet Gynecol Reprod Biol 1994, 54:197–203.
Rajan PB, Cranor ML, Rosen PP: Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients. Am J Surg Pathol 1998, 22:64–69. Highlights the natural history of phyllodes tumors in young patients.
Chaney AW, Pollack A, McNeese MD, et al.: Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000, 89:1502–1511. Largest recent series that discusses evidence for and against adjuvant XRT.
Powell CM, Rosen PP: Adipose differentiation in cystosarcoma phyllodes. A study of 14 cases. Am J Surg Pathol 1994, 18:720–727.
Silver SA, Tavassoli FA: Osteosarcomatous differentiation in phyllodes tumors. Am J Surg Pathol 1999, 23:815–821.
Reinfuss M, Mitus J, Smolak K, Stelmach A: Malignant phyllodes tumours of the breast. A clinical and pathological analysis of 55 cases. Eur J Cancer 1993, 29A:1252–1256.
Silverman JS, Tamsen A: Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages. Histopathology 1996, 29:411–419.
Aranda FI, Laforga JB, Lopez JI: Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblasts. Pathol Res Pract 1994, 190:471–481.
Umekita Y, Yoshida H: Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma. Pathol Int 1999, 49:807–810.
Millar EK, Beretov J, Marr P, et al.: Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology 1999, 34:491–496.
Lu Y, Birdsall S, Osin P, et al.: Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1 q copy number with stromal overgrowth and recurrence. Genes Chromosomes Cancer 1997, 20:275–281.
Barth Jr RJ: Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 1999, 57:291–295.
McGregor GI, Knowling MA, Este FA: Sarcoma and cystosarcoma phyllodes tumors of the breast—a retrospective review of 58 cases. Am J Surg 1994, 167:477–480.
Staren ED, Lynch G, Boyle C, et al.: Malignant cystosarcoma phyllodes. Am Surg 1994, 60:583–585.
Moffat CJ, Pinder SE, Dixon AR, et al.: Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology 1995, 27:205–218.
de Roos WK, Kaye P, Dent DM: Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast [see comments]. Br J Surg 1999, 86:396–399.
Hawkins RE, Schofield JB, Wiltshaw E, et al.: Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes. Cancer 1992, 69:2271–2275.
Allen R, Nixon D, York M, Coleman J: Successful chemotherapy for cystosarcoma phyllodes in a young woman. Arch Intern Med 1985, 145:1127–1128.
Burton GV, Hart LL, Leight Jr GS, et al.: Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer 1989, 63:2088–2092.
Chua CL, Thomas A, Ng BK: Cystosarcoma phyllodes— Asian variations. Aust N Z J Surg 1988, 58:301–305.
Stebbing JF, Nash AG: Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre. Ann R Coll Surg Engl 1995, 77:181–184.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khan, S.A., Badve, S. Phyllodes tumors of the breast. Curr. Treat. Options in Oncol. 2, 139–147 (2001). https://doi.org/10.1007/s11864-001-0056-y
Issue Date:
DOI: https://doi.org/10.1007/s11864-001-0056-y